FTXH
FTXH
About First Trust Nasdaq Pharmaceuticals ETF
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to...
About First Trust Nasdaq Pharmaceuticals ETF
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 VTRS | Viatris Inc. | 0.00% | 62.04K | $1.22M |
 ARWR | Arrowhead Pharmaceuticals, Inc. | 0.00% | - | $336.91K |
 ELAN | Elanco Animal Health Incorporated | 0.00% | 23.42K | $352.39K |
 EXEL | Exelixis, Inc. | 0.00% | 7.82K | $378.34K |
 KRYS | Krystal Biotech, Inc. | 0.00% | 440 | $219.41K |
 LGND | Ligand Pharmaceuticals Incorporated | 0.00% | - | $144.17K |
 LLY | Eli Lilly and Company | 0.00% | 622 | $1.24M |
 PRGO | Perrigo Company plc | 0.00% | 5.20K | $84.69K |
 PTCT | PTC Therapeutics, Inc. | 0.00% | 1.43K | $419.85K |
 PTGX | Protagonist Therapeutics, Inc. | 0.00% | - | $183.06K |
 REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 819 | $1.16M |
 BBIO | BridgeBio Pharma, Inc. | 0.00% | - | $150.58K |
 BIIB | Biogen Inc. | 0.00% | 4.08K | $1.23M |
 MDGL | Madrigal Pharmaceuticals, Inc. | 0.00% | 231 | $116.21K |
 MEDP | Medpace Holdings, Inc. | 0.00% | 870 | $260.21K |
 RYTM | Rhythm Pharmaceuticals, Inc. | 0.00% | - | $105.53K |
 ZTS | Zoetis Inc. | 0.00% | 3.42K | $722.36K |
 BMRN | BioMarin Pharmaceutical Inc. | 0.00% | 2.81K | $310.81K |
 BMY | Bristol-Myers Squibb Company | 0.00% | 19.21K | $2.28M |
 VRTX | Vertex Pharmaceuticals Incorporated | 0.00% | 165 | $1.10M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Ireland
NetherlandsSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Ireland NetherlandsHoldings (Top 20)
VTRS
Viatris Inc.
ARWR
Arrowhead Pharmaceuticals, Inc.
ELAN
Elanco Animal Health Incorporated
EXEL
Exelixis, Inc.
KRYS
Krystal Biotech, Inc.
LGND
Ligand Pharmaceuticals Incorporated
LLY
Eli Lilly and Company
PRGO
Perrigo Company plc
PTCT
PTC Therapeutics, Inc.
PTGX
Protagonist Therapeutics, Inc.
REGN
Regeneron Pharmaceuticals, Inc.
BBIO
BridgeBio Pharma, Inc.
BIIB
Biogen Inc.
MDGL
Madrigal Pharmaceuticals, Inc.
MEDP
Medpace Holdings, Inc.
RYTM
Rhythm Pharmaceuticals, Inc.
ZTS
Zoetis Inc.
BMRN
BioMarin Pharmaceutical Inc.
BMY
Bristol-Myers Squibb Company
VRTX
Vertex Pharmaceuticals Incorporated